Month: October 2020

Rymarz Zdort advised Nemera on the acquisition of Copernicus sp. z o.o. The final transaction documentation was executed on 27 October 2020.

Nemera is a world leader in the design, development and manufacturing of drug delivery devices, offering a comprehensive portfolio of products and services across ophthalmology, nasal, inhalation, dermal, transdermal and parenteral delivery. The acquisition of Copernicus, a Szczecin-based company that specialises in the design, development and manufacture of injection devices, and that also provides a comprehensive range of services related to the introduction of modern, intuitive drug delivery devices, not only strengthens the existing product offer of Nemera, but will also strengthen the company’s coverage in the Eastern European markets.

“Copernicus is recognised as one of the most innovative companies operating in the Polish healthcare industry; therefore, from the very beginning, our team was well aware of the crucial importance of this investment to our client. We are proud that we had an opportunity to support Nemera in such a significant transaction and we would like to thank the company for placing its trust and confidence in us”, said Dr Jakub Zagrajek, a partner in the corporate department of Rymarz Zdort.

The firm’s transaction team was led by Dr Jakub Zagrajek, assisted by attorneys from the corporate department: Dr Barbara Skardzinska, a senior associate, and Krystian Kowalski, an associate.

The team included Monika Kierepa, a partner in the corporate department who coordinated the work of the team that conducted the due diligence works.

The tax aspects of the transaction were handled by Robert Krasnodebski, a partner in the tax department, and Marek Kanczew, counsel in the same department, who also advised on employment-related issues connected with the transaction.

Rymarz Zdort advised the selling shareholders of ATM S.A., MCI.PrivateVentures (a subfund of MCI.EuroVentures 1.0) and AMC Capital IV Albatros S.à r.l. (a company advised by Mezzanine Management) on a transaction comprising the sale of 100% of the shares in ATM S.A. to Global Compute Infrastructure LP, a platform supported by Goldman Sachs Merchant Banking Division.

ATM is an IT company providing data transmission, collocation and internet access services to Polish and other telecommunications providers/operators, financial institutions and the media. It is the owner of the Atman network and three data centres. Its main shareholder, holding 98.33% of the shares, is AAW III sp. z o.o., a portfolio company of MCI.EuroVentures and AMC.

A conditional agreement was entered into on 17 October 2020, and the finalisation of the transaction will be subject to, among other things, antimonopoly clearances. On the basis of the concluded agreement, 796,099 shares in AAW III and 606,438 shares in ATM will be sold. The closing of the transaction is planned for the end of 2020.

“It was our first transaction with MCI and Mezzanine Management. We are proud to be involved in the largest exit, in terms of value, in MCI’s history. We would like to thank MCI and Mezzanine Management for their trust and great cooperation in the transaction process”, said Pawel Zdort, the managing partner of Rymarz Zdort.

The transaction team was supervised by Pawel Zdort. The team consisted of the following lawyers from the corporate department: Aleksandra Kabac, senior associate, and Aleksander Jakubisiak, associate, as well as Irmina Watly, counsel from the competition/antitrust practice, and Jerzy Rostworowski, a senior associate from the banking & finance practice, whereas Ewa Bober, a partner from the corporate department, advised on the structuring of the transaction.

It is our greatest pleasure to announce that Rymarz Zdort has again been recognised in a recent IFLR1000 ranking.

The recently published ranking regarded the M&A category, in which Rymarz Zdort has been ranked in Tier 1.

Additionally, nine lawyers of Rymarz Zdort have been recognised individually in this category.

Market Leader:

• Pawel Rymarz; and
• Pawel Zdort.

Highly regarded:

• Ewa Bober;
• Marek Durski;
• Dr hab. Lukasz Gasinski; and
• Iwona Her.

Rising Star:

• Dr Agnieszka Koniewicz

Notable Practitioner:

• Monika Kierepa; and
• Dr Filip Uzieblo.

Congratulations to all of the recognised attorneys and the M&A team.